Events

Expired
GLP-1s and Cardiovascular Risk in Patients with Type 2 Diabetes: Translating Outcomes Data into Clinical Practice
September 15, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
Upcoming
Heart Failure Redefined: Advancing Care in HFpEF and HFmrEF
September 16, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
September 17, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
September 24, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
September 29, 2026
5:30 pm
Meeting Objectives: Recognize patients with high-risk cSCC early in the treatment pathway who may be appropriate candidates for adjuvant therapy using current evidence and risk stratification criteria. Enhance multidisciplinary communication and referral strategies to engage pharmacists earlier in the treatment...
Upcoming
GLP-1s and Cardiovascular Risk in Patients with Type 2 Diabetes: Translating Outcomes Data into Clinical Practice
September 29, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
September 30, 2026
5:30 pm
Meeting Objectives: Recognize patients with high-risk cSCC early in the treatment pathway who may be appropriate candidates for adjuvant therapy using current evidence and risk stratification criteria. Enhance multidisciplinary communication and referral strategies to engage pharmacists earlier in the treatment...
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
October 1, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
October 1, 2026
5:30 pm
Meeting Objectives: Recognize patients with high-risk cSCC early in the treatment pathway who may be appropriate candidates for adjuvant therapy using current evidence and risk stratification criteria. Enhance multidisciplinary communication and referral strategies to engage pharmacists earlier in the treatment...
Upcoming
Optimizing Frontline Therapy for CML: Balancing Efficacy, Safety, and Long-Term Tolerability
October 8, 2026
5:30 pm
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency